[Prophylaxis of pyogenic complications in total replacement of large joints].
Results are studied of management of 378 patients having undergone total knee and hip arthroplasty over the period 1995-2001. Surgical interventions were undertaken in those patients presenting with osteoarthrosis deformans, rheumatoid arthritis, for complicated posttraumatic fractures, pathological fractures secondary to an oncological process. Pyo-inflammatory complications which necessitated removal of endoprothesis developed in nine (2.32%) patients. A strict keeping to the system of the purulent complications prophylaxis in total arthroplasty is an important component of a successful management of those patients presenting with grave forms of affections of the great joints.
Ternovyĭ
M K
MK
Kosiakov
O M
OM
Bulych
P V
PV
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D019643:Arthroplasty, Replacement / Q000009:adverse effects*; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects; D005260:Female; D006621:Hip Joint / Q000601:surgery; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects*; D007596:Joints / Q000601:surgery*; D007719:Knee Joint / Q000601:surgery; D007720:Knee Prosthesis / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D013492:Suppuration / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control
D000890:Anti-Infective Agents